Author:
Doubovetzky Michel,Ataman-Önal Yasemin,Chousterman Benjamin,Feroldi Emmanuel,Garçon Nathalie,Grillet Marie-Hélène,Kramer Daniel,Laurent Sébastien,Lewis David J.M.,Luna Ernesto,Manigold Tobias,Syntin Patrick,Burdin Nicolas,Fraisse Laurent,Jackson Nicholas
Subject
Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine
Reference72 articles.
1. FDA-NIH Biomarker Working Group. BEST (Biomarkers, EndpointS, and other Tools) Resource [Internet]: Silver Spring (MD): Food and Drug Administration (US), Co-published by National Institutes of Health (US), Bethesda (MD); 2016.
2. Potential use of inflammation and early immunological event biomarkers in assessing vaccine safety;Mastelic;Biologicals,2013
3. Vaccines against Lyme disease: what happened and what lessons can we learn?;Poland;Clin Infect Dis,2011
4. The first rotavirus vaccine and the politics of acceptable risk;Schwartz;Milbank Q,2012
5. BioVacSafe Project; 2019 [Last accessed 27 June 2019]. Available from: http://www.biovacsafe.eu/.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献